KCG
ROSG

Knight Capital Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Knight Capital Group’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$58K Buy
+1,418
New +$63K ﹤0.01% 3039

Other funds holding ROSG

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return

Knight Capital Group's ROSG Position: Q2 2013 in Review

Knight Capital Group opened a new position in Rosetta Genomics Ltd. (ROSG) in Q2 2013: 1,418 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #3039 among its holdings.

10 funds tracked by Wall St. Rank hold ROSG as of Q2 2013.

  • Knight Capital Group held 1,418 shares of Rosetta Genomics Ltd. worth $58K as of Q2 2013.
  • Rosetta Genomics Ltd. was a new Knight Capital Group position in Q2 2013.
  • Rosetta Genomics Ltd. made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #3039 holding.
  • 10 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.